Physician profile
Ashley Hrabik
NPI 1750741112
$1,348.53
in general payments reported to CMS, 2019-2025
17 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $264 · 2023: $296 · 2024: $454 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,084.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $232.72 | 2023-2024 | Ingrezza |
| Abbvie INC. | $186.41 | 2023-2025 | |
| Novo Nordisk INC | $123.80 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.80 | 2022 | |
| Abbott Laboratories | $120.78 | 2024 | Freestyle Libre |
| Janssen Pharmaceuticals, INC | $110.78 | 2023 | Spravato |
| Amgen INC. | $92.33 | 2024 | Tavneos |
| Novartis Pharmaceuticals Corporation | $73.92 | 2024-2025 | |
| Lilly USA, LLC | $56.56 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $47.84 | 2025 | |
| Janssen Biotech, INC. | $39.97 | 2025 | Tremfya |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.38 | 2025 | Spevigo |
| E.R. Squibb & Sons, L.L.C. | $29.53 | 2025 | Sotyktu |
| Leo Pharma INC. | $23.52 | 2025 | Adbry |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.57 | 2025 | Cabtreo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $19.91 | 2024 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $14.71 | 2024 | Libtayo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Hrabik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.